UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$383M |
| 2 |
DXC Technology
DXC
|
+$191M |
| 3 |
American Express
AXP
|
+$187M |
| 4 |
Johnson & Johnson
JNJ
|
+$185M |
| 5 |
TAL Education Group
TAL
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$228M |
| 2 |
Trane Technologies
TT
|
+$133M |
| 3 |
Booking.com
BKNG
|
+$131M |
| 4 |
MON
Monsanto Co
MON
|
+$113M |
| 5 |
EOG Resources
EOG
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.35% |
| 2 | Financials | 15.6% |
| 3 | Healthcare | 12.81% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDR
1251
DELISTED
McDermott International
MDR
| $2.89M | ﹤0.01% |
146,278
+5,152
| +4% | +$109K |
|
1252
ONE Gas
OGS
$4.84B
| $2.89M | ﹤0.01% |
39,395
+4,560
| +13% | +$346K |
|
1253
Graham Holdings Company
GHC
$5.08B
| $2.88M | ﹤0.01% |
5,158
-259
| -5% | -$147K |
|
|
USG
1254
DELISTED
Usg
USG
| $2.86M | ﹤0.01% |
74,124
+7,864
| +12% | +$276K |
|
1255
Encompass Health
EHC
$10.9B
| $2.86M | ﹤0.01% |
72,637
-23,559
| -24% | -$896K |
|
1256
Maximus
MMS
$3.29B
| $2.85M | ﹤0.01% |
39,799
-15,801
| -28% | -$1.06M |
|
1257
Evercore
EVR
$12.5B
| $2.84M | ﹤0.01% |
31,515
+629
| +2% | +$52.5K |
|
|
MNR
1258
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $2.83M | ﹤0.01% |
158,945
+24,344
| +18% | +$421K |
|
1259
Wolfspeed
WOLF
$1.38B
| $2.83M | ﹤0.01% |
76,173
+5,193
| +7% | +$179K |
|
1260
Curtiss-Wright
CW
$27.9B
| $2.83M | ﹤0.01% |
23,213
-3,671
| -14% | -$433K |
|
1261
Texas Capital Bancshares
TCBI
$4.44B
| $2.83M | ﹤0.01% |
31,789
+1,615
| +5% | +$140K |
|
1262
Choice Hotels
CHH
$4.97B
| $2.8M | ﹤0.01% |
36,141
+1,376
| +4% | +$101K |
|
1263
Brink's
BCO
$4.7B
| $2.78M | ﹤0.01% |
35,327
+1,714
| +5% | +$139K |
|
|
STL
1264
DELISTED
Sterling Bancorp
STL
| $2.78M | ﹤0.01% |
112,890
+37,395
| +50% | +$926K |
|
1265
Agree Realty
ADC
$9.47B
| $2.76M | ﹤0.01% |
53,741
+6,793
| +14% | +$337K |
|
1266
JetBlue
JBLU
$2.44B
| $2.75M | ﹤0.01% |
123,060
-171,161
| -58% | -$3.5M |
|
|
MIK
1267
DELISTED
Michaels Stores, Inc
MIK
| $2.74M | ﹤0.01% |
113,265
+24,481
| +28% | +$506K |
|
1268
Armstrong World Industries
AWI
$7.64B
| $2.73M | ﹤0.01% |
45,102
+1,344
| +3% | +$74K |
|
1269
American Eagle Outfitters
AEO
$3B
| $2.72M | ﹤0.01% |
144,816
+30,230
| +26% | +$456K |
|
|
SWN
1270
DELISTED
Southwestern Energy Company
SWN
| $2.72M | ﹤0.01% |
487,874
-8,988
| -2% | -$52.3K |
|
1271
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
| $2.72M | ﹤0.01% |
26,737
+791
| +3% | +$80.5K |
|
|
NVO
1272
Novo Nordisk
NVO
$210B
| $2.71M | ﹤0.01% |
101,100
+8,356
| +9% | +$213K |
|
|
KLXI
1273
DELISTED
KLX Inc.
KLXI
| $2.71M | ﹤0.01% |
47,057
+3,422
| +8% | +$164K |
|
1274
Avient
AVNT
$3.44B
| $2.68M | ﹤0.01% |
61,688
+3,995
| +7% | +$176K |
|
|
JUNO
1275
DELISTED
Juno Therapeutics, Inc.
JUNO
| $2.68M | ﹤0.01% |
58,690
+963
| +2% | +$48K |
|
Similar funds
UBS AM's Q4 2017 Portfolio in Review
As of Q4 2017, UBS AM held 2,665 positions worth $118B, up 7.5% from $110B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS AM's Q4 2017 filing shows 135 new, 1,412 increased, 606 reduced and 93 closed positions. Its largest new stake was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M. The largest sale was Celgene Corp, an estimated $228M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q4 2017 buy was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M.
- UBS AM added most to NetEase in Q4 2017, an estimated $383M increase.
- UBS AM's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $228M.
- UBS AM fully exited CR Bard Inc. in Q4 2017, selling an estimated $67.9M.
- UBS AM's ten largest holdings make up 16% of its $118B portfolio in Q4 2017.
- UBS AM opened 135 new positions and closed 93 in Q4 2017.
- UBS AM's portfolio value rose 7.5% quarter-over-quarter to $118B.
Based on UBS AM's 13F filing for Q4 2017, filed 9 Feb 2018.